Detalles de la búsqueda
1.
The association of screen time with intake of potentially cariogenic food and oral health of school children aged 8-14 years-a cross-sectional study.
J Clin Pediatr Dent
; 47(5): 116-123, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37732444
2.
Comparison of Fracture Strengths among different Commonly Placed Anterior Esthetic Restorations for Primary Dentition: An in vitro study.
J Clin Pediatr Dent
; 45(3): 171-176, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34192760
3.
Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis.
Rheumatology (Oxford)
; 58(2): 352-360, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30376130
4.
Effects of chronic kidney disease stage 4, end-stage renal disease, or dialysis on the plasma concentrations of ombitasvir, paritaprevir, ritonavir, and dasabuvir in patients with chronic HCV infection: pharmacokinetic analysis of the phase 3 RUBY-I and RUBY-II trials.
Eur J Clin Pharmacol
; 75(2): 207-216, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291369
5.
Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis.
Rheumatology (Oxford)
; 57(11): 1972-1981, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30032191
6.
Control of Anxiety in Pediatric Patients using "Tell Show Do" Method and Audiovisual Distraction.
J Contemp Dent Pract
; 19(9): 1058-1064, 2018 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287704
7.
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
J Infect Dis
; 215(4): 599-605, 2017 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28329334
8.
Pharmacokinetic Evaluation of Darunavir Administered Once or Twice Daily in Combination with Ritonavir or the Three-Direct-Acting Antiviral Regimen of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults Coinfected with Hepatitis C and Human Immunodeficiency Viruses.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27919899
9.
Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.
N Engl J Med
; 370(3): 222-32, 2014 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24428468
10.
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
Gastroenterology
; 150(7): 1590-1598, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26976799
11.
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials.
Br J Clin Pharmacol
; 83(3): 527-539, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662429
12.
Comparison of Complications in Removable Mandibular Acrylic Splint and Cantilever Herbst for Management of Class II Malocclusion: A Retrospective Study.
J Contemp Dent Pract
; 18(5): 363-365, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512273
13.
Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.
Clin Infect Dis
; 62(8): 972-9, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26740513
14.
Drug-Drug Interaction between the Direct-Acting Antiviral Regimen of Ombitasvir-Paritaprevir-Ritonavir plus Dasabuvir and the HIV Antiretroviral Agent Dolutegravir or Abacavir plus Lamivudine.
Antimicrob Agents Chemother
; 60(10): 6244-51, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27503645
15.
Evaluation of Drug-Drug Interactions between Direct-Acting Anti-Hepatitis C Virus Combination Regimens and the HIV-1 Antiretroviral Agents Raltegravir, Tenofovir, Emtricitabine, Efavirenz, and Rilpivirine.
Antimicrob Agents Chemother
; 60(5): 2965-71, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26953200
16.
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir.
Antimicrob Agents Chemother
; 60(1): 105-14, 2016 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26459906
17.
Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans.
Drug Metab Dispos
; 44(8): 1164-73, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179127
18.
Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment.
J Hepatol
; 63(4): 805-12, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26070406
19.
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir.
J Hepatol
; 63(1): 20-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25646891
20.
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
JAMA
; 313(12): 1223-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25706092